Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Human leukocyte antigen class II expression is a good prognostic factor in adult T-cell leukemia/lymphoma.

Takeuchi M, Miyoshi H, Asano N, Yoshida N, Yamada K, Yanagida E, Moritsubo M, Nakata M, Umeno T, Suzuki T, Komaki S, Muta H, Furuta T, Seto M, Ohshima K.

Haematologica. 2019 Aug;104(8):1626-1632. doi: 10.3324/haematol.2018.205567. Epub 2019 Jan 10.

2.

Epidemiology and secular trends of malignant lymphoma in Japan: Analysis of 9426 cases according to the World Health Organization classification.

Muto R, Miyoshi H, Sato K, Furuta T, Muta H, Kawamoto K, Yanagida E, Yamada K, Ohshima K.

Cancer Med. 2018 Nov;7(11):5843-5858. doi: 10.1002/cam4.1805. Epub 2018 Oct 11.

3.

Clinicopathological analysis of immunohistochemical expression of retinoic acid-related orphan receptor-γt in peripheral T-cell lymphoma, not otherwise specified.

Yanagida E, Miyoshi H, Kawamoto K, Nakashima K, Matsuda K, Yamada K, Muto R, Nagafuji K, Seto M, Ohshima K.

Hum Pathol. 2018 Sep;79:86-92. doi: 10.1016/j.humpath.2018.05.002. Epub 2018 Jun 22.

PMID:
29775622
4.

Pulmonary pleomorphic carcinoma: A case harboring EGFR mutation treated with EGFR-TKIs.

Masuda K, Tokito T, Azuma K, Yanagida E, Nakamura M, Naito Y, Matsuo N, Ishii H, Yamada K, Akiba J, Hoshino T.

Thorac Cancer. 2018 Jun;9(6):754-757. doi: 10.1111/1759-7714.12646. Epub 2018 Apr 19.

5.

Prognostic factors for histiocytic and dendritic cell neoplasms.

Shimono J, Miyoshi H, Arakawa F, Sato K, Furuta T, Muto R, Yanagida E, Sasaki Y, Kurita D, Kawamoto K, Nagafuji K, Ohshima K.

Oncotarget. 2017 Oct 19;8(58):98723-98732. doi: 10.18632/oncotarget.21920. eCollection 2017 Nov 17.

6.

[Pathology of malignant lymphoma in gastric intestinal tracts].

Ohshima K, Yanagida E, Mutou R.

Nihon Shokakibyo Gakkai Zasshi. 2017;114(11):1939-1947. doi: 10.11405/nisshoshi.114.1939. Japanese. No abstract available.

PMID:
29109342
7.

Frequent expression of CD30 in extranodal NK/T-cell lymphoma: Potential therapeutic target for anti-CD30 antibody-based therapy.

Kawamoto K, Miyoshi H, Suzuki T, Sasaki Y, Yamada K, Yanagida E, Muto R, Kiryu M, Sone H, Seto M, Ohshima K, Takizawa J.

Hematol Oncol. 2018 Feb;36(1):166-173. doi: 10.1002/hon.2482. Epub 2017 Oct 20.

PMID:
29052238
8.

Clinicopathological features of cryptococcal lymphadenitis and a review of literature.

Kawamoto K, Miyoshi H, Suzuki T, Muto R, Yamada K, Yanagida E, Koshino M, Sasaki Y, Takizawa J, Sone H, Sugita Y, Seto M, Ohshima K.

J Clin Exp Hematop. 2017 Jul 5;57(1):26-30. doi: 10.3960/jslrt.17011. Epub 2017 Jun 8. Review.

9.

Comparison of clinicopathological characteristics between T-cell prolymphocytic leukemia and peripheral T-cell lymphoma, not otherwise specified.

Kawamoto K, Miyoshi H, Yanagida E, Yoshida N, Kiyasu J, Kozai Y, Morikita T, Kato T, Suzushima H, Tamura S, Muta T, Kato K, Eto T, Seki R, Nagafuji K, Sone H, Takizawa J, Seto M, Ohshima K.

Eur J Haematol. 2017 May;98(5):459-466. doi: 10.1111/ejh.12856. Epub 2017 Mar 3.

PMID:
28129454

Supplemental Content

Loading ...
Support Center